Skip to main content
# Title Department Research Year
221 Preclinical validation of a novel oral Edaravone formulation for treatment of frontotemporal dementia 2021
222 Towards understanding of the interaction of certain carbapenems with protein via combined experimental and theoretical approach Department of Pharmaceutical Analytical Chemistry 2021
223 Design, synthesis, and biological evaluation of novel EGFR inhibitors containing 5-chloro-3-hydroxymethyl-indole-2-carboxamide scaffold with apoptotic antiproliferative activity Department of Pharmaceutical Organic Chemistry 2021
224 Colorimetric and fluorometric nanoprobe for selective and sensitive recognition of hazardous colorant indigo carmine in beverages based on ion pairing with nitrogen doped carbon dots Department of Pharmaceutical Analytical Chemistry 2021
225 Novel 2-Indolinone Based derivatives Targeting Cell Cycle Checkpoint’s Proteins as Potential Anticancer Agents Department of Medicinal Chemistry 2021
226 Silver Nanoparticle-Coated Ethyl Cellulose Inhibits Tumor Necrosis Factor-α of Breast Cancer Cells Department of Industrial Pharmacy 2021
227 The protein tyrosine phosphatase SHP-1 (PTPN-6) but not CD45 (PTPR-C) is essential for the ligand-mediated regulation of CD22 in BCR-ligated B cells Department of Pharmaceutical Organic Chemistry 2021
228 Novel Urea Linked Ciprofloxacin-Chalcone Hybrids having Antiproliferative Topoisomerases I/II Inhibitory Activities and Caspases-Mediated Apoptosis Department of Pharmaceutical Organic Chemistry 2021
229 Enhanced molecular imprinted electrochemical sensing of histamine based on signal reporting nanohybrid Department of Pharmaceutical Organic Chemistry 2021
230 Ultra-small lipid nanoparticles encapsulating sorafenib and midkine-siRNA selectively-eradicate sorafenib-resistant hepatocellular carcinoma in vivo Department of Industrial Pharmacy 2021